FORWARD PHARMA
Forward Pharma is a privately held biotechnology company focused on the immunomodulatory compound dimethyl fumarate and derivatives, for applications as a pharmaceutical drug product to treat immune disorders such as multiple sclerosis and psoriasis. Forward Pharma A/S was founded in 2005 and is headquartered in Copenhagen, Denmark, in the heart of Medicon Valley. Since 2007 we have also operated out of a subsidiary, Forward Pharma GmbH, in Leipzig, Germany, and since August 2014 out of a subsidiary in the United States, Forward Pharma USA, LLC.
FORWARD PHARMA
Industry:
Biopharma Biotechnology Pharmaceutical
Founded:
2005-01-01
Address:
Copenhagen, Hovedstaden, Denmark
Country:
Denmark
Website Url:
http://www.forward-pharma.com
Total Employee:
11+
Status:
Active
Contact:
+45 33 44 42 42
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Apple Mobile Web Clips Icon WordPress Apache Euro Microsoft Exchange Online Office 365 Mail
Current Advisors List
Current Employees Featured
Stock Details
Official Site Inspections
http://www.forward-pharma.com
- Host name: linux141.unoeuro.com
- IP address: 94.231.103.157
- Location: Denmark
- Latitude: 55.7123
- Longitude: 12.0564
- Timezone: Europe/Copenhagen
More informations about "Forward Pharma"
FORWARD PHARMA
Forward Pharma Wins New Honor of "SRDI Small- & Medium-Sized Enterprise" December 16, 2022. Forward Pharma wins 7.75 million award from Shenzhen government funds. View All …See details»
Investors – Forward Pharma
Forward Pharma A/S is a Danish biopharmaceutical company that from 2005 to 2017 developed a proprietary formulation of DMF for the treatment of inflammatory and neurological indications. …See details»
Forward Pharma - Crunchbase Company Profile
Forward Pharma is a privately held biotechnology company focused on the immunomodulatory compound dimethyl fumarate and derivatives, for …See details»
Forward Pharma - Crunchbase Company Profile
Forward Pharma specializes in the research and development of next-generation small-molecule pharmaceuticals and antibody-targeted drugs. It focuses on …See details»
Our Company-FORWARD PHARMA
Dec 16, 2022 Forward Pharma wins new honor of "SRDI Small- & Medium-Sized Enterprise" December 16, 2022. Forward Pharma Wins 7.75 Million Award From Shenzhen Government …See details»
Management – Forward Pharma
Prior to joining Forward Pharma in 2015, he held positions of increasing seniority in the Danish pharmaceutical company Novo Nordisk A/S, including roles of Global Medical Director for …See details»
Forward Pharma A/S
Forward Pharma A/S Østergade 24 A, 1., DK-1100 København K Annual Report for 1 January - 31 December 2021 CVR No28 86 58 80 The Annual Report was presented and adopted at the …See details»
Forward Pharma - VentureRadar
Forward Pharma (Shenzhen Forward Pharmaceutical Co., Ltd) is a national high-tech enterprise dedicated to international innovative drug research and development in oncology and …See details»
Our Team-FORWARD PHARMA
He returned to China in 2014 to start his own business. Founded in 2015, Forward Pharmaceuticals Co., Ltd has independently developed several new drug products including "the fourth generation of non-small cell lung cancer …See details»
Forward Pharma - Funding, Financials, Valuation & Investors
Forward Pharma specializes in the research and development of next-generation small-molecule pharmaceuticals and antibody-targeted drugs.See details»
Forward Pharma A/S - AnnualReports.com
Forward Pharma A/S is a Danish biopharmaceutical company that commenced development in 2005 of a proprietary formulation of DMF for the treatment of inflammatory and neurological indications. The Company granted to Biogen …See details»
expertise-FORWARD PHARMA
Precision medicine in Forward is a comprehensive integration of deep scientific insights, cutting-edge technologies, and rich industry experience. ... Forward Pharma became the first strategic …See details»
Forward Pharma Company Profile 2024: Stock Performance
Forward Pharma General Information Description. Provider of medical components for diseases intended for the treatment of inflammatory and neurological indications. The company …See details»
Board of directors – Forward Pharma
Dr. Moore has served on our board of directors since May 2016. Dr. Moore is a partner at East West Capital Partners since May 2008. Previously, Dr. Moore was a top-ranked …See details»
Investor FAQs – Forward Pharma
Forward Pharma A/S | Strandvejen 125 | DK-2900 Hellerup | Denmark | [email protected] | Legal statement ...See details»
ALL-FORWARD PHARMA
Forward Pharma Is Selected As One of THE "2020 Guangdong-Hong Kong-Macao Greater Bay Area Innovation Power Enterprises" January 1, 2021. FDA Clears Forward’s Innovative …See details»
Forward Pharma Reports Financial and Operational Results
COPENHAGEN, Denmark, April 14, 2021 (GLOBE NEWSWIRE) -- Forward Pharma A/S (NASDAQ:FWP) (“We,” “Forward” or the “Company” and, together with its subsidiaries, the …See details»
General Meeting – Forward Pharma
Forward Pharma A/S – Årsrapport 2023. Appendix 2 – Vedtaegter (AoA) – Forward Pharma – (COMPARE) ANNUAL GENERAL MEETING 2023. Documents (English language) Results of …See details»
September 3, 2021-FORWARD PHARMA
FWD1509 is Forward Pharma 's flagship product FWD1509 is a new generation of targeted tyrosine kinase inhibitors EGFR/HER2 exon20 insertion mutations. The main indication is non …See details»